R Preston Mason

Title: R Preston Mason: Innovator in Cardiovascular Treatments

Introduction

R Preston Mason is a notable inventor based in Manchester, MA (US), recognized for his contributions to the field of cardiovascular medicine. With a total of four patents to his name, Mason has focused on developing innovative solutions aimed at improving health outcomes related to platelet aggregation and cardiovascular diseases.

Latest Patents

Mason's latest patents include significant advancements in the use of carotenoid analogs and derivatives for the prevention of platelet aggregation. These embodiments are directed towards compositions that utilize carotenoid analogs or derivatives to treat disorders associated with platelet aggregation. The patents also describe pharmaceutical compositions that combine these carotenoid analogs with additional medicaments to enhance treatment efficacy. Another notable patent features compositions comprising nebivolol, which has been shown to be beneficial in treating cardiovascular diseases such as hypertension and congestive heart failure. This invention highlights a pharmaceutical composition that includes nebivolol alongside other active cardiovascular agents.

Career Highlights

Throughout his career, Mason has worked with various companies, including Cardax Pharmaceuticals, Inc. His work has significantly impacted the development of treatments for cardiovascular conditions, showcasing his commitment to advancing medical science.

Collaborations

Mason has collaborated with notable individuals in the field, including Samuel Fournier Lockwood and Eric Davis. These partnerships have contributed to the innovative research and development of his patented technologies.

Conclusion

R Preston Mason's work exemplifies the spirit of innovation in the medical field, particularly in cardiovascular treatments. His patents reflect a dedication to improving patient care through scientific advancements.